EMA Authorised: Signifor (pasireotide) — Recordati Rare Diseases

View source ↗

Summary

Signifor (pasireotide) has been authorised in the EU for acromegaly and pituitary ACTH hypersecretion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Pituitary Acth Hypersecretion

Drugs mentioned

• SIGNIFOR (PASIREOTIDE)

Snippet

Status: Authorised. Therapeutic area: Acromegaly;Pituitary ACTH Hypersecretion. MAH: Recordati Rare Diseases. Decision date: 16/12/2024